Wearable Robotic Functional Assistance for Stroke Rehabilitation
NCT ID: NCT00396708
Last Updated: 2010-02-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2006-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Personalized Upper Extremity Rehabilitation for Persons With Stroke
NCT03903770
Virtual Reality-Integrated Propulsion Feedback for Stroke Rehab
NCT07087743
Effects of Rehabilitation Robots-Morning Walk in Individuals With Hemiparesis
NCT06374706
Robot-Assisted Motivating Rehabilitation
NCT00393926
Therapeutic Effects of a New Upper Limb Robot Assisted Therapy Device for Persons After Stroke
NCT01723046
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The intervention for the study will be for the control group- 6-8 weeks of therapeutic exercise and functional training for a total of 18 hours of intervention, or the case group- 6-8 weeks of therapeutic exercise and functional training with the use of the AJB for a total of 18 hours of intervention. Each session will be one hour in length. The length of the study and length of each session is per standard rehabilitation protocol that has been well documented in previous studies as well as the pilot study regarding the AJB. A pre and post test with a 3 month follow up of all measures will be included in the study.
Study procedures will focus on performing functional tasks using the e100.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
myomo e100 neurorobotic elbow brace
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Cognitive Awareness
* Weakness in upper arm
* Over 1 year post CVA
* not engaged in any other upper arm therapies
Exclusion Criteria
* Very high elbow tone (arm rigid in flexion or extension)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Myomo
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Myomo,Inc
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kailas N Narendran, BS, MEng
Role: PRINCIPAL_INVESTIGATOR
Inventor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
myomo Inc.
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Myomo Inc. Homepage
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.